RxDoctor Payments Data

Stacey Rothwell, PA

Medical · Charleston, SCNPI 1912982844

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Radius Health, Inc. accounts for 62.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,744 and has fallen 61.3% since, to $1,062 in 2025.

$4,964in general payments, 2019–2025

Across 73 payments — averaging $68.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$3K
  • Amgen$1K
  • Relievant Medsystems, Inc.$152
  • Kyowa Kirin, Inc.$113
  • AstraZeneca$112
  • Sanofi$104
  • plus $181 from 4 others

What the payments were for

  • Speaking & faculty fees$1,70034%
  • Travel & lodging$55311%
  • Food & beverage$2,71155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,964 in reported general payments places this provider in the 85th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$54,908
Medicare patients
399
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ForteoTeriparatide192$773,470
TymlosAbaloparatide167$523,232
Teriparatide79$218,750
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic135$7,608
Risedronate Sodium33$2,288
Celecoxib73$1,192
Alendronate Sodium50$388
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$263
Gabapentin23$191
Oxycodone Hcl27$120
Methocarbamol14$85
Easy Touch Alcohol Prep PadsAlcohol Antiseptic Pads24$67
Tramadol Hcl19$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$3,088$523,232167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 384 medical providers in South Carolina.

Other medical in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →